The Chinese biopharmaceutical company Sinovac Biotech Ltd. on Monday announced its H1N1 (swine) flu vaccine won the approval of a panel of experts from China’s State Food and Drug Administration, the Associated Press/Forbes reports.
The number of H1N1 (swine) flu cases are steadily declining in the Southern Hemisphere as the region’s flu season comes to an end, the WHO said Friday, the Associated Press reports.
The H1N1 (swine) flu is blamed for 557 deaths in Brazil, “making it the country with the highest number of fatalities in the world from the disease,” according to the country’s health ministry, Agence France-Presse reports.
A spokesperson for the WHO said on Tuesday that Asia will not have enough H1N1 vaccines for swine flu when cold weather hits, Reuters reports.
A U.S. presidential panel report released Monday estimates H1N1 (swine) flu could infect up to half of the country’s population, the Washington Post reports.
The WHO’s flu chief Keiji Fukuda on Saturday called upon wealthy nations and vaccine manufacturers to donate H1N1 (swine) flu vaccines to developing countries, the Associated Press reports.
According to the latest WHO report out Wednesday, the number of confirmed H1N1 (swine) flu deaths since its emergence in April has reached 1,799 â€“ a jump from 1,462 deaths since the agency’s last update, Agence France-Presse/the Australian reports.
“Northern hemisphere countries have so far ordered more than one billion doses of swine flu vaccine, the World Health Organisation said Tuesday, sparking warnings over shortages,” Agence France-Presse reports.
Also In Global Health News: Sri Lanka’s IDPs; Zimbabwe Doctor Strike; Nigerian HIV Marriages; Tracking Disease In India
Heavy Rains Worsen Health Conditions For IDPs In Sri Lanka “Heavy rains exacerbated poor conditions for hundreds of thousands of internally displaced people (IDPs) in northern Sri Lanka over the weekend,” IRIN reports. “From an epidemiological point of view, this is a public health disaster waiting to happen,” an international…
HHS announced on Monday that manufacturing and packaging issues have reduced by more than half the number of H1N1 vaccine doses that will be available in October when the U.S. vaccination campaign is set to start, Reuters reports.